These findings propose that ST2 and IL-33 are attending in ovarian cancer TM, and there may be IL-33/ST2 axis activation in ovarian cancer TM in CAFs and epithelial cells (Figures 4F, H). This evidence concerns the gene IL33 and ovarian cancer.